NOVIGENIX
Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for the detection of disease, therapy optimization, and disease recurrence monitoring to improve disease management and patient outcomes. The Novigenix proprietary LITOseek platform is optimized for mapping the response of the immune system to onset and progression of disease by integrating patient multi-omics data, advanced Machine Learning, and artificial intelligence approaches, to provide actionab... le insights and precision solutions for optimization of patient’s therapeutic journey. Our product pipeline currently includes patient stratification solutions in the field of Immuno-Oncology, Colorectal Cancer early detection and recurrence monitoring, and therapy optimization solutions for management of cancer patients. Novigenix provides services to Pharma and Biotech customers by leveraging the proprietary LITOseek data analytics and patient clinical data platform to deliver previously unknown insights into the immune system, and develop ImmunoTranscriptomic solutions with actionable biomarkers for optimization of new therapeutic modalities.
NOVIGENIX
Industry:
Artificial Intelligence Biotechnology Health Diagnostics Life Science Machine Learning Predictive Analytics
Founded:
2014-01-01
Address:
Epalinges, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.novigenix.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1000 K EUR
Technology used in webpage:
IPv6 Person Schema Gravatar Profiles Java EE QuoVadis
Current Employees Featured
Founder
Investors List
Eurostars
Eurostars investment in Grant - NOVIGENIX
Official Site Inspections
http://www.novigenix.com
- Host name: novigenix.com
- IP address: 93.88.247.115
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "NOVIGENIX"
Novigenix
Using AI and RNA sequence analysis, Novigenix captures the cancer immunity cycle during the multi-stage disease progression and response to therapy. Novigenix has a proven track record …See details»
NOVIGENIX - Crunchbase Company Profile & Funding
Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for the detection of disease, therapy optimization, and disease recurrence monitoring to …See details»
NOVIGENIX - The Org
Novigenix is a precision medicine company that specializes in ImmunoTranscriptomic solutions. View NOVIGENIX's up-to-date org chart, open roles, and culture details. Find executives, …See details»
OUR STORY - Novigenix
We are a pioneering company made up of experienced, bold and dedicated individuals with a clear understanding of complex host immune response pathways and data-driven intelligent …See details»
Novigenix - Novigenix
Basée en Suisse, au cœur d’un centre d’excellence pour la lutte contre le cancer, l’entreprise Novigenix se concentre sur le développement de tests sanguins pour la détection précoce de maladies du système gastro-intestinal.See details»
Novigenix Company Profile 2024: Valuation, Funding & Investors
Developer of a precision medicine platform designed for the detection of disease, therapy optimization, and disease recurrence monitoring to improve disease management and patient …See details»
Novigenix SA - BioAlps
Novigenix’s unique Immuno-Transcriptomic platform enables an accelerated identification of disease specific mRNA signatures of immune cells, which combined with machine learning …See details»
Novigenix SA - LinkedIn
Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for early detection of disease, development of novel therapeutics, and drug target discovery.See details»
NOVIGENIX's Leadership Team - Team members and org chart
The leadership team at NOVIGENIX has a history of experience in the fields of banking and finance, entrepreneurship and venture capital, applied physics and biophysics, management of …See details»
Novigenix SA - VentureRadar
Novigenix is pioneering the Immuno-Transcriptomics platform that measures changes in the expression of genes that are being transcribed by peripheral blood immune cells such as B …See details»
NOVIGENIX - Funding, Financials, Valuation & Investors
Novigenix is a precision medicine company that specializes in ImmunoTranscriptomic solutions.See details»
Novigenix SA - Swiss Biotech
Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for the detection of disease, therapy optimization, and disease recurrence monitoring to …See details»
NOVIGENIX - Contacts, Employees, Board Members, Advisors
NOVIGENIX has 7 current employee profiles, including Co-Founder and Director Scientific and Clinical Affairs Laura Ciarloni. Novigenix is a precision medicine company that specializes in …See details»
Management-board - Novigenix
Novigenix is an innovative precision medicine company offering liquid biopsy multi-omic solutions powered by the LITOSeek™ AI-RNA analytics platform for better patient outcomes.See details»
Revolutionizing Drug Development: Novigenix Unveils AI-Powered …
Jan 17, 2024 · Novigenix is on a mission to improve the cancer treatment landscape, leveraging advanced AI and RNA analysis from a routine blood draw to provide more precise insights into …See details»
Revolutionizing Drug Development: Novigenix Unveils AI
Jan 17, 2024 · With a decade-long track record, Novigenix successfully launched Colox® blood test in Switzerland, powered by AI and RNA analysis to detect early-stage colon cancer, …See details»
Revolutionizing Drug Development: Novigenix Unveils AI-Powered …
Jan 17, 2024 · Novigenix is on a mission to improve the cancer treatment landscape, leveraging advanced AI and RNA analysis from a routine blood draw to provide more precise insights into …See details»
Novigenix announces first closing of its $20M Series B financing …
LAUSANNE, SWITZERLAND – November 15, 2022 – Novigenix SA, a leading data-driven precision medicine biotech that develops and commercializes Immuno-Transcriptomic …See details»
國家華語測驗推動工作委員會 - tocfl.edu.tw
移工留才久用方案專區. 民國111年4月30日正式實施之「移工留才久用方案」，社福類申請者可提具華語文能力測驗口語能力「基礎級」以上之證明，欲報考者請詳見「移工留才久用方案專區 …See details»
Novigenix Announces Election of Dr. Miro Venturi to its Board of ...
Company expands precision medicine solutions for drug development and clinical utility programs. LAUSANNE, SWITZERLAND – August 31, 2021 – Novigenix SA, a leading Swiss biotech that …See details»